Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Enhancing Cognitive and Postoperative Recovery After Cardiac Surgery in Older Adults (ECPON II) (ECPON II)

13. November 2026 aktualisiert von: Ulrica Nilsson, Karolinska Institutet

Enhancing Cognitive Function and POstoperative Neurocognitive Recovery After Cardiac Surgery in Older Adults

Postoperative cognitive complaints are common among older adults undergoing cardiac surgery and may negatively affect recovery, daily functioning, independence, and quality of life. The ECPON II study evaluates the effectiveness of a co-designed, nurse navigator-led intervention designed to support cognitive and postoperative recovery in older adults undergoing cardiac surgery.

Fifty patients aged 65 years or older undergoing cardiac surgery will receive the intervention. Outcomes will be compared with data from 150 matched historical controls from the previous ECPON observational study (ECPON I; NCT06469515). The historical controls are not enrolled in ECPON II.

The intervention consists of four coordinated components: information and education, postoperative consultations, cognitive assessments, and peer support, coordinated and delivered by a nurse navigator. The primary outcome is patient-reported cognitive complaints. Secondary outcomes include postoperative recovery, cognitive function, delirium, frailty, depression, health-related quality of life, functional capacity, self-efficacy, caregiver burden, and cost-utility. Participants will be followed for six months after surgery.

Studienübersicht

Status

Noch keine Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

Postoperative neurocognitive impairment and cognitive complaints are important complications following cardiac surgery in older adults. Cognitive complaints may include difficulties with memory and concentration, fatigue, sleep disturbances, and reduced ability to manage everyday activities. These problems may influence postoperative recovery, independence, rehabilitation, and quality of life and may also affect close relatives.

ECPON II is a quasi-experimental superiority study evaluating a co-designed intervention coordinated and delivered by a nurse navigator. The intervention was developed through an experience-based co-design process involving older adults who had undergone surgery, close relatives, healthcare professionals, and scientific experts.

The intervention comprises four core components: (1) information and education regarding postoperative cognitive difficulties and strategies for managing them; (2) individualized postoperative consultations with a nurse navigator; (3) cognitive assessments before and after surgery to identify and follow cognitive difficulties and support individualized postoperative care; and (4) peer-support sessions for patients and close relatives.

Fifty patients aged 65 years or older undergoing open cardiac surgery will be prospectively enrolled and receive the intervention. Each patient will be asked to nominate a close relative who will be invited to participate in selected study activities. Close relatives will provide assessments of the patient's cognitive functioning and caregiver burden and may participate in peer-support sessions and qualitative interviews. If the patient has no close relative or the nominated person declines participation, the patient remains eligible for the study.

Outcomes in the intervention group will be compared with data from 150 matched historical controls from ECPON I (NCT06469515), an observational study conducted in the same patient population. The historical controls are used as comparator data and are not included in the ECPON II enrollment.

The primary objective is to determine whether the intervention reduces patient-reported cognitive complaints following cardiac surgery. Secondary objectives include evaluating postoperative recovery, cognitive function, self-efficacy, functional status, fatigue, depression, frailty, health-related quality of life, caregiver burden, and cost-utility.

A purposive sample of approximately 20-40 patients and their close relatives will participate in semi-structured individual interviews six months after surgery to explore experiences of the intervention, mechanisms of impact, feasibility, postoperative cognition, and recovery. In addition, all patients will be asked about any experience with postoperative delirium and, if so, to describe any long-term experiences as well as overall experience of postoperative cognition and its impact on recovery.

Studientyp

Interventionell

Einschreibung (Geschätzt)

50

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studieren Sie die Kontaktsicherung

Studienorte

      • Gothenburg, Schweden
        • Sahlgrenska University Hospital, Gothenburg
        • Kontakt:
          • Tor Damén, MD, PhD

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

65 Jahre und älter (Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Nein

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Scheduled for elective or urgent open-heart surgery or minimally invasive cardiac surgery
  • Resident in the area/region for the current thoracic clinic
  • Able to read and understand Swedish

Exclusion Criteria:

  • Physical, mental, and cognitive difficulties that prevent the individual from completing the cognitive tests
  • Undergone surgery within the last 6 months

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Unterstützende Pflege
  • Zuteilung: N / A
  • Interventionsmodell: Einzelgruppenzuweisung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: ECPON II Nurse Navigator-led Intervention

The intervention comprises four coordinated components:

  1. Information and education: Verbal and written information about cognitive difficulties after cardiac surgery, their impact on daily life and recovery, and strategies for managing them.
  2. Postoperative consultations: An individual consultation with the nurse navigator 2-3 weeks after discharge, addressing recovery, challenges, support, and self-management. A person-centred care plan is developed, with additional consultations as needed.
  3. Cognitive assessment: Cognitive function, cognitive complaints, daily functioning, and recovery are assessed before and after surgery to guide individualized support.
  4. Peer support: Small-group sessions for patients and close relatives, facilitated by the nurse navigator, focus on shared experiences, self-management, and recovery.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Patient-reported cognitive complaints
Zeitfenster: Preoperatively and weekly from 3-5 days after discharge through 6 months after surgery.

Patient-reported cognitive complaints will be assessed using the Cognitive Recovery dimension of the Swedish Quality of Recovery-Cognitive (SwQoR-Cog). The dimension comprises 10 items assessing symptoms related to cognitive complaints, including fatigue, sleep difficulties, concentration difficulties, frustration, forgetfulness, difficulties reading or calculating, and reduced ability to function independently. Each symptom is rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time"), with higher scores indicating a greater symptom burden.

Preoperatively and weekly from 3-5 days after discharge through 6 months after surgery.

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Postoperative recovery
Zeitfenster: Preoperatively and weekly through 6 months

Evaluated with the General recovery dimension of the SwQoR-Cog, consisting of 4 items measuring symptoms related to pain, nausea, the wound, and difficulties with personal hygiene. Each item is rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time"), with higher scores indicating a greater symptom burden.

Preoperatively and weekly through 6 months
Nightmares
Zeitfenster: Weekly through 6 months

Patient-reported frequency/severity of nightmares rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time").

Weekly through 6 months
Cognitive function
Zeitfenster: Preoperatively, 1 month, 3 months and 6 months

Consortium to Establish a Registry for Alzheimer's Disease (CERAD). The CERAD measures verbal learning and memory performance. Participants are presented with a list of 10 words across three learning trials and asked to recall as many words as possible after each trail.

Preoperatively, 1 month, 3 months and 6 months
Executive functioning
Zeitfenster: Preoperatively, 1 month, 3 months and 6 months

Stroop Colour-Word Interference Test (SCWT) is used to assess executive functioning, selective attention, and inhibitory control. In this timed test, participants are required to identify the colour of words printed in incongruent colours as quickly and accurately as possible

Preoperatively, 1 month, 3 months and 6 months
Postoperative delirium
Zeitfenster: Three times daily during hospitalization

Nursing Delirium Screening Scale (Nu-DESC). The scale assesses five symptom domains associated with delirium, with higher scores reflecting greater symptom severity. A total score of 2 or above is considered indicative of delirium.

Three times daily during hospitalization
Frailty
Zeitfenster: Preoperatively and 6 months

Clinical Frailty Scale (CFS), a nine-point instrument that classifies individuals from very fit to terminally ill. Assessments are conducted by trained clinicians based on the individual's pre-illness functional status.

Preoperatively and 6 months
Depressive symptoms
Zeitfenster: Preoperatively, 1 month, 3 months and 6 months

Patient Health Questionnaire-9 (PHQ-9), nine items assessing depressive symptoms experienced during the preceding two weeks, with response options ranging from 0 ("not at all") to 3 ("nearly every day").

Preoperatively, 1 month, 3 months and 6 months
Health-related quality of life
Zeitfenster: Preoperatively and 6 months

RAND-36 questionnaire encompassing eight dimensions of health: physical functioning, physical role limitations, emotional role limitations, vitality, mental health, social functioning, pain, and general health. Domain scores as well as physical and mental summary scores will be calculated to provide an overall assessment of health status.

Preoperatively and 6 months
Functional capacity
Zeitfenster: Preoperatively, 1 month, 3 months and 6 months

World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0), 12-item version. This instrument evaluates difficulties in performing everyday activities and participating in daily life in relation to an individual's current health status. Each item is rated on a five-point scale reflecting the degree of difficulty experienced, generating a total score ranging from 0 to 48. Higher scores indicate greater disability and functional limitations

Preoperatively, 1 month, 3 months and 6 months
Self-efficacy
Zeitfenster: Preoperatively, 1 month, 3 months and 6 months

General Self-Efficacy Scale (GSE), 10 items assessing an individual's perceived ability to handle demanding situations and solve problems effectively. Items are rated on a four-point scale, and higher scores reflect greater self-efficacy.

Preoperatively, 1 month, 3 months and 6 months
Cognitive functioning assessed by close relatives
Zeitfenster: Preoperatively, 1 month, 3 months and 6 months

Cognitive Failures Questionnaire for Others (CFQ-f). The questionnaire contains eight items measuring observed cognitive difficulties in daily life, with responses provided on a five-point scale from never to always. The instrument has been translated and culturally adapted for Swedish use by our research group following back-translation procedures. The recall period was shortened from six months in the original version to one month to better reflect the postoperative recovery trajectory.

Preoperatively, 1 month, 3 months and 6 months
Caregiver burden
Zeitfenster: Preoperatively, 1 month, 3 months and 6 months

Zarit Burden Interview, 12-item version (ZBI-12). The instrument contains 12 items, each rated on a five-point Likert scale ranging from never to nearly always.

Preoperatively, 1 month, 3 months and 6 months
Plasma osmolality
Zeitfenster: Preoperatively and postoperative day 1

Osmolality will be estimated using the blood-based biomarkers sodium, glucose, and urea and calculated according to the following formula: Osmolarity (mOsm/L) = 2 × Sodium (mmol/L) + Glucose (mg/dL) / 18 + Urea (mg/dL) / 2.8.

Preoperatively and postoperative day 1
Cost-utility
Zeitfenster: Through 6 months

Will be assessed by calculating quality-adjusted life years (QALYs) gained using data obtained from the RAND-36.

Through 6 months

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Demographic and perioperative data
Zeitfenster: At baseline and perioperatively

Will be collected from the medical record.

At baseline and perioperatively

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Geschätzt)

1. Januar 2027

Primärer Abschluss (Geschätzt)

1. Dezember 2027

Studienabschluss (Geschätzt)

1. Dezember 2027

Studienanmeldedaten

Zuerst eingereicht

13. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

13. November 2026

Zuerst gepostet (Tatsächlich)

19. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

19. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

13. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • 2026-06328-01

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .